Chinese Drugmaker InnoCare Gets $160M Investment Led By PE Firm Loyal Valley Capital

Chinese biotech company Beijing InnoCare Pharma Tech Co. (InnoCare) has secured a US$160 million new round of financing led by the country’s private equity investment management firm Loyal Valley Capital, according to a statement released on InnoCare’s website on Friday.

China Money Network

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech


Register Now

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!


Already have an account or paid subscription? Log in

LEAVE A REPLY